OLA Blog

WKD: Propaganda or Facts?!

Written by Meguid El Nahas on Wednesday, 08 March 2017. Posted in OLA Blog

WKD: Propaganda or Facts?!
The 2017 WKD theme is Obesity and CKD implying a link between the incidence, progression and outcomes of CKD and Obesity. Whilst I am aware of links between Obesity and the Metabolic syndrome, and between the metabolic Syndrome and...

OLA Tweet: Salt Restriction in CKD

Written by Meguid El Nahas on Sunday, 19 February 2017. Posted in OLA Blog

OLA Tweet: Salt Restriction in CKD
Prof Pierre Delanaye TWEETED:    A cheap and (relatively) simple intervention to improve HTA in CKD! Don't forget it! This is a RCT!     Clin J Am Soc Nephrol. 2017 Feb 16. pii: CJN.01120216. doi:...

AVF: Fish Oil, Aspirin or Nothing...?

Written by Meguid El Nahas on Saturday, 14 January 2017. Posted in OLA Blog

AVF: Fish Oil, Aspirin or Nothing...?
Prof Pierre Delanaye posted: FISH OIL or ASPIRIN for AVF maturation: does not wok!Written by Pierre Delanaye on Monday, 09 January 2017. Posted in OLA BlogJAMA Intern Med. 2017 Jan 3. doi: 10.1001/jamainternmed.2016.8029. [Epub ahead of...

ELEVATE: Rather not....

Written by Meguid El Nahas on Wednesday, 04 January 2017. Posted in OLA Blog

ELEVATE: Rather not....
Am J Transplant. 2016 Dec 27. doi: 10.1111/ajt.14186. [Epub ahead of print] Early conversion from calcineurin inhibitor- to everolimus-based therapy following kidney transplantation: Results of the randomized ELEVATE trial....

ASN 2016: Onco-Nephrology

Written by Meguid El Nahas on Wednesday, 23 November 2016. Posted in OLA Blog

ASN 2016: Onco-Nephrology
Prof Richard Glassock wrote: I went to a session on Onco-Nephrology at the ASN meeting yesterday.  Two randomized controlled trials of high-cut off (HCO) membrane intermittent hemodialysis compared to standard membrane hemodialysis for...

ASN 2016: Late Breaking Clinical Trials

Written by Meguid El Nahas on Sunday, 20 November 2016. Posted in OLA Blog

ASN 2016: Late Breaking Clinical Trials
Prof Arif Khwaja Reporting from Chicago: Late Breaking Clinical Trials LEADER study looking at Liraglutatide on renal outcomes in patients with T2DM. This was a huge study with over 8000 patients with T2DM at higher CV risk who were randomised...

PPIs & CKD: "Do No Harm"...?!

Written by Meguid El Nahas on Monday, 17 October 2016. Posted in OLA Blog

PPIs & CKD: "Do No Harm"...?!
BLOG BY PROFESSOR PIERRE DELANAYE: PPI and CKD: an association… but is it causality? Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease. JAMA Intern Med. 2016 Feb;176(2):238-46. doi: 10.1001/jamainternmed.2015.7193....

A RCT trial in hemodialysis patients: fistula

Written by Pierre Delanaye on Monday, 10 October 2016. Posted in OLA Blog

A RCT trial in hemodialysis patients: fistula
Lancet. 2016 Sep 10;388(10049):1067-74. doi: 10.1016/S0140-6736(16)30948-5. Epub 2016 Aug 1. Effect of regional versus local anaesthesia on outcome after arteriovenous fistula creation: a randomised controlled trial. Aitken...

Radiocontrast Nephrotoxicity: A Myth?!

Written by Meguid El Nahas on Friday, 07 October 2016. Posted in OLA Blog

Radiocontrast Nephrotoxicity: A Myth?!
J Am Soc Nephrol. 2016 Sep 29. pii: ASN.2016010021. [Epub ahead of print] Estimating the Risk of Radiocontrast-Associated Nephropathy. Wilhelm-Leen E, Montez-Rath ME, Chertow G Abstract Estimates of the incidence...

Highlights from the 17th IPNA Congress "Molecular stratification of the nephrotic syndrome”

Written by Neveen A Soliman on Wednesday, 05 October 2016. Posted in OLA Blog

Highlights from the 17th IPNA Congress "Molecular stratification of the nephrotic syndrome”
During the plenary session of the first day of the 17th International Pediatric Nephrology A ssociation Congress, September 20-24 in Iguacu, Brazil  Professor Moin A Saleem delivered the keynote talk entitled “Molecular...